Here are some developments:
• Cellvizio received MHLW regulatory approval in Japan in April 2014 and is now installed in 10 leading hospitals throughout the country including the National Cancer Center Hospital in Tokyo.
• Dr. Ken Ohata, director of endoscopy at NTT Medical Center Tokyo, performed the first-ever live procedure involving the use of Cellvizio in Japan on March 7.
• More than 25 leading physicians from Japan will take part in the upcoming International Conference of Cellvizio Users to be held in Lisbon on April 10.
More articles on GI/endoscopy:
Removing Barriers to Colorectal Cancer Screening Act introduced: 5 things to know
7 things for gastroenterologists to know for today – March 16, 2015
Norgine, Arc Medical partner to distribute colonoscopy device ENDOCUFF VISION
